Showing results (81-90 of 111) with videos related to

Sort By:
Pageof 12
Epilepsy & Behavior : E&B|June 18, 2013
Tiagabine in clinical practice: effects on seizure control and behaviorDavid G Vossler, George L Morris, Cynthia L Harden, et al.
Neurology|April 12, 2019
Assessment and effect of a gap between new-onset epilepsy diagnosis and treatment in the USLinda Kalilani, Edward Faught, Hyunmi Kim, et al.
Epilepsy & Behavior : E&B|October 8, 2011
Registry initiated to characterize vision loss associated with vigabatrin therapyJohn M Pellock, Edward Faught, Robert C Sergott, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|January 21, 2012
Clinical outcomes, quality of life, and costs associated with implantation of vagus nerve stimulation therapy in pediatric patients with drug-resistant epilepsySandra L Helmers, Mei Sheng Duh, Annie Guérin, et al.
Epilepsy & Behavior : E&B|May 22, 2016
Which children receive vigabatrin? Characteristics of pediatric patients enrolled in the mandatory FDA registryJohn M Pellock, Edward Faught, Rod Foroozan, et al.
Annals of Neurology|April 25, 2006
Magnetic source imaging versus intracranial electroencephalogram in epilepsy surgery: a prospective studyRobert C Knowlton, Rotem Elgavish, Jennifer Howell, et al.
Epilepsy & Behavior : E&B|August 30, 2011
Clinical and economic impact of vagus nerve stimulation therapy in patients with drug-resistant epilepsySandra L Helmers, Mei Sheng Duh, Annie Guérin, et al.
Archives of Neurology|August 16, 2006
Race/ethnicity, sex, and socioeconomic status as predictors of outcome after surgery for temporal lobe epilepsyJorge G Burneo, Lorie Black, Roy Martin, et al.
Pageof 12